Key clinical point: Additional options for the preventive treatment of episodic cluster headache may be needed.
Major finding: About 48% of patients use acute therapy only, and 48% use preventive treatments.
Study details: An analysis of data from the Adelphi 2017 Cluster Headache Disease Specific Programme, a cross-sectional survey.
Disclosures: Eli Lilly funded the study.
Nichols R et al. AHS 2019. Abstract OR04.